Statement by MassBio President & CEO Robert K. Coughlin on the Appointment of Dr. Michelle McMurry-Heath as BIO’s New CEO

May 14, 2020

“MassBio is thrilled with the appointment of Dr. Michelle McMurry-Heath as BIO’s incoming President and CEO. Dr. McMurry-Heath’s time on Capitol Hill, at the FDA, the American Association for the Advancement of Science, and inside industry leading external innovation and regulatory science gives her the perfect blend of experience and expertise to lead the life sciences industry. She has committed her life to patients and helping to address unmet medical needs around the world, and beyond that is a role model for what it takes to succeed. As the first African-American to graduate from Duke’s Medical Scientist Training Program, Dr. McMurry-Heath understands the critical need to improve the diversity of voices and opinions in the life sciences across all levels. We look forward to working with and learning from Dr. McMurry-Heath as we enter a new era for biopharma innovation.”

– Bob Coughlin, President & CEO, MassBio

See all MassBio News